These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6673027)

  • 1. [Can normovolemic hemodilution really modify blood flow in the limbs?].
    Guerrini M; Pieragalli D; Acciavatti A; Cappelli R; Pecchi S; Forconi S; Di Perri T
    Ric Clin Lab; 1983; 13 Suppl 3():439-44. PubMed ID: 6673027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normovolemic hemodilution in peripheral arterial disease.
    Rieger H; Köhler M; Schoop W; Schmid-Schönbein H
    Ann Clin Res; 1981; 13 Suppl 33():78-83. PubMed ID: 7342848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamics in controlled normovolemic hemodilution in patients with obliterative vascular diseases].
    Kuznetsov NA
    Vestn Khir Im I I Grek; 1986 Feb; 136(2):126-31. PubMed ID: 3518191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
    Weidinger P; Bilek M; Tekusch A
    Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
    [No Abstract]   [Full Text] [Related]  

  • 8. [The influence of hemorrheology on the practice of clinical medicine].
    Dormandy JA
    Ric Clin Lab; 1983; 13 Suppl 3():7-27. PubMed ID: 6369497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isovolemic hemodilution as a functional therapy of decompensated arteriosclerotic stenoses of the femoral, cerebral and ophthalmic artery.
    Schmid-Schönbein H; Rieger H
    Ric Clin Lab; 1983; 13 Suppl 3():29-52. PubMed ID: 6673004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
    Artale F; Sergio G; Cramarossa L; Giunti P; Francisci A; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():411-5. PubMed ID: 6673022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rheologic effects of normovolemic hemodilution].
    Kuznetsov NA; Aleksandrova NP; Bogdanov AE; Rogulenko RV
    Anesteziol Reanimatol; 1990; (2):18-22. PubMed ID: 1698041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of regional blood circulation in normovolemic hemodilution in patients with arterial occlusive diseases].
    Kuznetsov NA; Bogdanov AE
    Vestn Khir Im I I Grek; 1987 Sep; 139(9):19-24. PubMed ID: 3441964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rheological effects of normovolemic hemodilution].
    Cozette P; Gaillard S; Rose E; Carnielo M
    Ann Anesthesiol Fr; 1979; 20(9):775-83. PubMed ID: 45288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multi-distributed ischemia and degree of hemorrheological changes].
    Sergio G; Artale F; Francisci A; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():427-30. PubMed ID: 6673025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A; Schmidt HH; Sternitzky R
    Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diluted albumin-dextran 40 combination in treating arteriopathy of the lower extremities by normovolemic hemodilution. The rheological effects].
    Stoltz JF; Chevraud C; Voisin P; Burdin D; Streiff F; Laxenaire MC
    J Mal Vasc; 1986; 11(4):344-50. PubMed ID: 2433377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
    Rieger H
    Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
    Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
    Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
    Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.